← Back to Search

Patients with Voice Disorders for Swallowing Difficulty (MoCA Trial)

N/A

Waitlist Available

Led By Clark Rosen, MD

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up recorded at initial clinic visit and follow-up visit after completion of speech therapy. typically a time scale of 6-12 weeks depending on how soon speech/swallow/upper airway therapy is started.

Awards & highlights

MoCA Trial Summary

This trial will see if the MoCA test predicts how well older patients with laryngology problems do in voice, swallowing, or upper airway therapy.

Eligible Conditions

Swallowing Difficulty
Cognitive Impairment
Laryngeal Disorders
Cognitive Decline
Voice Disorders

MoCA Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ recorded at initial clinic visit and follow-up visit after completion of speech therapy. typically a time scale of 6-12 weeks depending on how soon speech/swallow/upper airway therapy is started.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~recorded at initial clinic visit and follow-up visit after completion of speech therapy. typically a time scale of 6-12 weeks depending on how soon speech/swallow/upper airway therapy is started.

This trial's timeline: 3 weeks for screening, Varies for treatment, and recorded at initial clinic visit and follow-up visit after completion of speech therapy. typically a time scale of 6-12 weeks depending on how soon speech/swallow/upper airway therapy is started. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Cough Severity Index Score Following Therapy

Dyspnea

Change in Eating Assessment Tool-10 Score Following Therapy

+1 more

Secondary outcome measures

Change in Acoustic Voice Quality Index (AVQI) as Measured in the VoiceEvalu8 App Following Therapy

Change in DIGEST Scale Score Following Therapy

Change in Functional Oral Intake Scale (FOIS) Score Following Therapy

+3 more

MoCA Trial Design

3Treatment groups

Active Control

Group I: Patients with Voice DisordersActive Control1 Intervention

This is typically diagnosed by MDs in conjunction with Speech Language Pathologists (SLPs).

Group II: Patients with Swallowing DisordersActive Control1 Intervention

This is typically diagnosed by MDs in conjunction with Speech Language Pathologists (SLPs).

Group III: Patients with Upper Airway DisordersActive Control1 Intervention

This is typically diagnosed by MDs in conjunction with Speech Language Pathologists (SLPs).

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Emory UniversityOTHER

1,638 Previous Clinical Trials

2,560,475 Total Patients Enrolled

New York UniversityOTHER

226 Previous Clinical Trials

314,060 Total Patients Enrolled

University of California, San FranciscoLead Sponsor

2,505 Previous Clinical Trials

15,237,498 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there still opportunities to join this clinical trial?

"As shown on clinicaltrials.gov, this trial has not been actively seeking candidates since December 24th 2021; its original posting was made March first 2021. Alternatively, there are 1584 other trials that are currently enrolling participants."

Answered by AI

What objectives are being sought after through this clinical trial?

"This clinical trial's primary aim is to measure the difference in Eating Assessment Tool-10 Scores post therapy. Other outcomes, such as Functional Oral Intake Scale (FOIS) Score and Iowa Oral Performance Instrument (IOPI) following treatment will be monitored along with changes in voice fundamental frequency measured through VoiceEvalu8 app for patients undergoing vocal or upper airway therapy. The timeframe of this study spans 6-12 weeks depending on how soon speech/swallow/upper airway interventions commence."

Answered by AI

Recent research and studies

The LaryngoscopeJournal

The Prevalence of Cognitive Impairment in Laryngology Treatment–seeking Patients

Leclerc, Andrée‐Anne, Amanda I. Gillespie, Stasa D. Tadic, Libby J. Smith, and Clark A. Rosen. 2019. “The Prevalence of Cognitive Impairment in Laryngology Treatment–seeking Patients”. The Laryngoscope. Wiley. doi:10.1002/lary.28355.

The LaryngoscopeJournal

Development and Validation of the Cough Severity Index: A Severity Index for Chronic Cough Related to the Upper Airway

Shembel, Adrianna C., Clark A. Rosen, Thomas G. Zullo, and Jackie L. Gartner-Schmidt. 2013. “Development and Validation of the Cough Severity Index: A Severity Index for Chronic Cough Related to the Upper Airway”. The Laryngoscope. Wiley. doi:10.1002/lary.23916.

Journal of VoiceJournal

Development and Validation of the Dyspnea Index (DI): A Severity Index for Upper Airway–related Dyspnea

Gartner-Schmidt, Jackie L., Adrianna C. Shembel, Thomas G. Zullo, and Clark A. Rosen. 2014. “Development and Validation of the Dyspnea Index (DI): A Severity Index for Upper Airway–related Dyspnea”. Journal of Voice. Elsevier BV. doi:10.1016/j.jvoice.2013.12.017.

The LaryngoscopeJournal